Isto Biologics strengthens its bone graft substitutes platform with the acquisition of NovaBone
HOPKINTON, MA – August 5, 2026 – Isto Biologics (“Isto”), a biologics company dedicated to advancing bone healing, today announced the acquisition of NovaBone Products LLC…

